CI vs EDIT
Cigna Corp (CI) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CI and EDIT stock pages for the full models.
Not investment advice.